---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-001963"
form_type: "8-K"
ticker: "DQWS"
cik: "0001652561"
company_name: "DSwiss Inc"
filed_at: "2023-01-20T23:59:59+00:00"
generated_at: "2026-06-20T12:32:30.875883+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# DSwiss (HK) acquires remaining 60% of DSwiss Biotech for nominal RM1

## Summary
- Acquired 150,000 shares (60%) of DSwiss Biotech Sdn Bhd from shareholder Jervey Choon on Jan 18, 2023.
- Purchase price: nominal fee of RM1 (approx. $0.23).
- DSBT supplies biotech products in Malaysia with in-house R&D.
- DSwiss (HK) now owns 100% of DSBT; acquisition closed as of Jan 18, 2023.
- No material financial impact disclosed; consideration is trivial.

## SEC filing metadata
- accession: 0001493152-23-001963
- form_type: 8-K
- ticker: DQWS
- cik: 0001652561
- company_name: DSwiss Inc
- filed_at: 2023-01-20T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1652561/000149315223001963/0001493152-23-001963-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1652561/000149315223001963/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-001963
- JSON: https://secwatch.observer/filing/0001493152-23-001963.json
- Plain text: https://secwatch.observer/filing/0001493152-23-001963.txt

## Key facts
- M&A Transactions
  DSwiss Inc completed an acquisition involving Jervey Choon for USD 0.23 (closed 2023-01-18).
  - Action: acquisition
  - Counterparty: Jervey Choon
  - Consideration: USD 0.23
  - Closing: 2023-01-18
  source text: DSwiss Biotech Sdn Bhd from a shareholder, Jervey Choon, pursuant to which DSHK acquired 100% of DSBT. As consideration thereof, DSHK agreed to make the proceeds payment of USD 0.23 to the shareholder. DSwiss Biotech Sdn Bhd primarily operates in Malaysia by supplying biotech products to their clients as set forth below: Name Business Description DSwiss
  evidence_url: https://www.sec.gov/Archives/edgar/data/1652561/000149315223001963/0001493152-23-001963-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.